Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-17-002321
Filing Date
2017-06-08
Accepted
2017-06-08 17:07:44
Documents
62
Period of Report
2017-04-30

Document Format Files

Seq Description Document Type Size
1 c88560_10q.htm 10-Q 664435
2 c88560_ex31-1.htm EX-31.1 10436
3 c88560_ex31-2.htm EX-31.2 10451
4 c88560_ex32-1.htm EX-32.1 3717
5 c88560_ex32-2.htm EX-32.2 3314
  Complete submission text file 0000930413-17-002321.txt   4175692

Data Files

Seq Description Document Type Size
6 enz-20170430.xml EX-101.INS 990425
7 enz-20170430.xsd EX-101.SCH 49912
8 enz-20170430_cal.xml EX-101.CAL 42644
9 enz-20170430_def.xml EX-101.DEF 197388
10 enz-20170430_lab.xml EX-101.LAB 315427
11 enz-20170430_pre.xml EX-101.PRE 208154
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 17900853
SIC: 8071 Services-Medical Laboratories